Hosted on MSN1y
Study describes structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP
A recent article in the journal Nature Communications describes the structural basis of mimicked HBV/HDV viral peptide drug interaction with its receptor NTCP. HBV, an enveloped DNA virus, causes ...
Nature2y
Hepatitis B: The Hunt for a Killer Virus
At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...
Frontiers12d
Host factors in hepatitis B virus: Mechanistic insights and implications for interferon therapy
Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk ...
FDA clears Precision BioSciences’ IND for PBGENE-HBV to treat HBV
Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...